Clinical trials. Company, researchers battle over data access.
A dispute between university-based researchers and the corporation that funded their study is threatening to erupt into a $7 million to $10 million legal battle. Last week, the researchers reported that a large clinical trial of an immune system booster to treat HIV-infected people found that the drug isn't effective in slowing progression to AIDS or reducing mortality. The company that developed the drug tried to block publication of the study unless the researchers included the company's analysis of a subset of the data that suggests the drug might help some people. The researchers refused.
Morton
C C
CC
D016915:AIDS Vaccines / Q000627:therapeutic use*; D002140:California; D003627:Data Interpretation, Statistical; D018450:Disease Progression; D004345:Drug Industry; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D017008:Negotiating; D011643:Publishing; D016032:Randomized Controlled Trials as Topic; D014495:Universities; D019562:Viral Load
D016915:AIDS Vaccines; C105086:remune